91 related articles for article (PubMed ID: 25446077)
1. HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr⁻/⁻ mice.
Kim J; Kim CS; Jo K; Cho YS; Kim HG; Lee GH; Lee YM; Sohn E; Kim JS
Biochem Biophys Res Commun; 2015 Jan; 456(1):53-8. PubMed ID: 25446077
[TBL] [Abstract][Full Text] [Related]
2. Sipjeondaebo-tang, a traditional herbal formula, inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Lee YM; Kim CS; Sohn E; Jo K; Lim HR; Kim SK; Kim JS; Kim J
Tohoku J Exp Med; 2014 Nov; 234(3):229-36. PubMed ID: 25365937
[TBL] [Abstract][Full Text] [Related]
3. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A.
Dong A; Seidel C; Snell D; Ekawardhani S; Ahlskog JK; Baumann M; Shen J; Iwase T; Tian J; Stevens R; Hackett SF; Stumpp MT; Campochiaro PA
Angiogenesis; 2014 Jul; 17(3):553-62. PubMed ID: 24154861
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.
Roberts WG; Whalen PM; Soderstrom E; Moraski G; Lyssikatos JP; Wang HF; Cooper B; Baker DA; Savage D; Dalvie D; Atherton JA; Ralston S; Szewc R; Kath JC; Lin J; Soderstrom C; Tkalcevic G; Cohen BD; Pollack V; Barth W; Hungerford W; Ung E
Cancer Res; 2005 Feb; 65(3):957-66. PubMed ID: 15705896
[TBL] [Abstract][Full Text] [Related]
7. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
[TBL] [Abstract][Full Text] [Related]
8. Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.
Xia CH; Lu E; Zeng J; Gong X
PLoS One; 2013; 8(9):e75186. PubMed ID: 24058663
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.
Silva RLE; Kanan Y; Mirando AC; Kim J; Shmueli RB; Lorenc VE; Fortmann SD; Sciamanna J; Pandey NB; Green JJ; Popel AS; Campochiaro PA
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100839
[TBL] [Abstract][Full Text] [Related]
10. Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
Zhou L; Sun X; Huang Z; Zhou T; Zhu X; Liu Y; Wang J; Cheng B; Li M; He C; Liu X
Cell Physiol Biochem; 2018; 48(1):263-273. PubMed ID: 30007969
[TBL] [Abstract][Full Text] [Related]
11. [Study on effects of curcumin on expressions of PDGF-BB, PDGFRbeta and ERK1 of HSC].
Zhao ZD; Huang ZS
Zhong Yao Cai; 2009 May; 32(5):732-5. PubMed ID: 19771848
[TBL] [Abstract][Full Text] [Related]
12. Loss of VLDL receptor activates retinal vascular endothelial cells and promotes angiogenesis.
Jiang A; Hu W; Meng H; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):844-50. PubMed ID: 18936153
[TBL] [Abstract][Full Text] [Related]
13. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells.
Sufen G; Xianghong Y; Yongxia C; Qian P
Cell Biol Int; 2011 May; 35(5):545-51. PubMed ID: 20961291
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of Brazilin on the vascular smooth muscle cell proliferation and migration induced by PDGF-BB.
Guo J; Li L; Wu YJ; Yan Y; Xu XN; Wang SB; Yuan TY; Fang LH; Du GH
Am J Chin Med; 2013; 41(6):1283-96. PubMed ID: 24228601
[TBL] [Abstract][Full Text] [Related]
15. Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.
Iwase T; Oveson BC; Hashida N; Lima e Silva R; Shen J; Krauss AH; Gale DC; Adamson P; Campochiaro PA
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):503-11. PubMed ID: 23169884
[TBL] [Abstract][Full Text] [Related]
16. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
Bäckman U; Christofferson R
Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
[TBL] [Abstract][Full Text] [Related]
17. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
[TBL] [Abstract][Full Text] [Related]
18. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.
Sabuda-Widemann D; Grabensee B; Schwandt C; Blume C
Nephrol Dial Transplant; 2009 Jan; 24(1):52-61. PubMed ID: 18723570
[TBL] [Abstract][Full Text] [Related]
20. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
